Supplement and bioactive manufacturers struggle to get their active ingredients absorbed by the human body
Supplement companies invest heavily in bioactive compounds, but 60-80% of these ingredients pass through the digestive system without being absorbed, making products ineffective and wasting R&D investment. Current delivery methods (pills, powders, liquids) fail to protect bioactives from stomach acid and liver metabolism, forcing manufacturers to either reformulate at high cost or accept poor efficacy claims that limit market appeal. This directly impacts product efficacy, customer satisfaction, repeat purchases, and regulatory compliance.
Validation Scores
Overall Score: 33.0%
Payment Evidence (1)
Payment Type Saas
Payment intent for saas: app
From: BioClé tackles bioactives’ bioavailability challenge with novel delivery tech
Source Signals (1)
The tech utilizes tiny bacterial extracellular vesicles, which have a natural affinity for intestinal cells and can be loaded with bioactives. The post BioClé tackles bioactives’ bioavailability challenge with novel delivery tech appeared first on AgFunderNews ....
Generated Solutions
No solutions generated yet
Generate a solution (sign in)Sign in and use 1 credit to generate a buildable solution.
Problem Details
- Category
- healthcare
- Pain Keywords
- bioavailability, nutrient absorption, supplement efficacy, delivery mechanism, intestinal permeability, active ingredient loss
- Signals Collected
- 1
- Created
- 2026-10-28 00:20